Objective: Evaluation of the effects of camel milk, camel dough and cow milk on blood glucose, insulin resistance, lipid profile and blood pressure in patients with type 2 diabetes.
Design: Randomized, Single blind
Setting and conduct:
A- Participants including major eligibility criteria
- Major inclusion criteria: Patients with type 2 diabetes
- Major exclusion criteria: Insulin injection and having cardiovascular and renal diseases
- Sample size: 45
B- Intervention: 500 cc camel milk, caw milk or camel dough
C- Intervention Time: 2 months
D- Main outcome: Blood sugar, insulin resistance, lipid profile and blood pressure
General information
Acronym
IRCT registration information
IRCT registration number:IRCT201302044794N7
Registration date:2013-02-18, 1391/11/30
Registration timing:registered_while_recruiting
Last update:
Update count:0
Registration date
2013-02-18, 1391/11/30
Registrant information
Name
Fereidoun Azizi
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 21 2240 9309
Email address
azizi@endocrine.ac.ir
Recruitment status
Recruitment complete
Funding source
Vice chancellor for Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences
Expected recruitment start date
2012-12-21, 1391/10/01
Expected recruitment end date
2013-08-21, 1392/05/30
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Effect of camel milk on blood sugar, insulin resistance, lipid profile and blood pressure in type 2 diabetic patients.
Public title
camel milk and type 2 diabetes
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion Criteria: Patients with type 2 diabetes; age range: 20 to 70 years old; treatment with diet or oral anti-diabetic drugs. Exclusion Criteria: Treatment with insulin; pregnancy or lactation; smoking and alcohol consumption; body mass index greater than 35 kg/m2 ; Lactose intolerance; taking estrogenic drugs and corticosteroids; having cardiovascular disease, liver, lung, kidney and Chronic gastrointestinal and thyroid dysfunction; following from the weight loss diets two months prior to study; weight changes (increase or decrease) more than 5 kg two months prior to study
Age
From 20 years old to 70 years old
Gender
Both
Phase
2-3
Groups that have been masked
No information
Sample size
Target sample size:
45
Randomization (investigator's opinion)
Randomized
Randomization description
Blinding (investigator's opinion)
Single blinded
Blinding description
Placebo
Used
Assignment
Parallel
Other design features
Secondary Ids
empty
Ethics committees
1
Ethics committee
Name of ethics committee
Ethics committee, Research Institute For Endocrine Sciences, Shahid Beheshti University of Medical S